Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Oncobiologics, Inc.
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Oncobiologics, Inc. since year 2005.
Table 2 shows the detailed insider transactions of Oncobiologics, Inc. since 2005.
The reporting company's ticker symbol is ONS. The reporting company's CIK number is 1649989.
The total value of stock buying since 2005 is $0.
The total value of stock sales since 2005 is $577,580.
The total value of stock option exercises since 2005 is $0.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2018-01-04||Mohan Pankaj (President & CEO)||Sale||62,569||1.16||72,580|
|2018-01-03||Mohan Pankaj (President & CEO)||Sale||52,108||1.18||61,487|
|2017-12-22||Yamashita Elizabeth A. (VP, Regulatory Affairs)||Sale||16,170||1.13||18,272|
|2017-12-22||Bahrt Kenneth (Chief Medical Officer)||Sale||26,165||1.13||29,566|
|2017-12-22||Kenyon Lawrence A (CFO and Secretary)||Sale||26,165||1.13||29,566|
|2017-12-22||Mcandrew Stephen J (SVP Bus. Strat. & Dev.)||Sale||15,705||1.13||17,746|
|2017-12-19||Mohan Pankaj (President & CEO)||Sale||83,608||1.14||95,313|
|2017-12-19||Yamashita Elizabeth A. (VP, Regulatory Affairs)||Sale||6,151||1.14||7,012|
|2017-12-18||Mohan Pankaj (President & CEO)||Sale||20,523||1.17||24,011|
|2017-12-18||Yamashita Elizabeth A. (VP, Regulatory Affairs)||Sale||1,509||1.17||1,765|
|2016-11-23||Griffith Donald J.||Sale||1||3.75||3|
|2016-11-11||Gangloff Scott A. (SVP, Development & Mfrg)||Sale||37,369||3.75||140,133|
|2016-11-11||Mcandrew Stephen J (SVP Bus. Strat. & Dev.)||Sale||21,367||3.75||80,126|
|2016-11-09||Gangloff Scott A. (SVP, Development & Mfrg)||Option Ex||115,942||.00||0|
|2016-11-09||Griffith Donald J.||Option Ex||144,927||.00||0|
|2016-11-09||Brady Todd C||Option Ex||28,985||.00||0|
|2016-11-09||Canute Scott A||Option Ex||57,971||.00||0|
|2016-11-09||Mcandrew Stephen J (SVP Bus. Strat. & Dev.)||Option Ex||57,971||.00||0|
|2016-05-13||Bahrt Kenneth (Chief Medical Officer)||Buy||2,000||.00||0|
Insider trading activities including stock purchases, stock sales, and option exercises of ONS listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Oncobiologics, Inc. (symbol ONS, CIK number 1649989) see the Securities and Exchange Commission (SEC) website.